Navigation Links
BSP Granted CE Mark for its HyperQ AD-100 Product Enabling Improved Diagnostic Performance of Stress ECG
Date:6/29/2010

TEL AVIV, Israel, June 29, 2010 /PRNewswire-FirstCall/ -- BSP, which develops and commercializes advanced products for the non invasive, accurate diagnosis of heart diseases, announced today that its Add-On product, the HyperQ AD-100 (http://www.bsp.co.il/pdf/HyperQ AD-100 Pic.pdf), intended for improved diagnostic performance of Stress ECG, has been granted the European CE conformance mark. The HyperQ AD-100 product is an add-on system with the HyperQ technology which is incorporated in parallel to existing standard stress ECG systems. The integration of the HyperQ AD-100 into Stress ECG systems enables accurate and sensitive diagnosis of Ischemic Heart Disease, a leading cause of death in the world.

The unique technology developed by BSP is implemented in a non invasive manner and does not involve exposure to radiation or other hazards to patients. It is highly effective in diagnosing sick people and in ruling out disease in healthy individuals. The HyperQ AD-100 enables physicians to benefit from the clinical advantages of the technology without the need to replace their existing installed Stress ECG system.

BSP CEO, Nissim Greisas: "The integration of the HyperQ Add-On systems into the vast installed base of standard Stress ECG systems significantly expands our potential global market. The worldwide annual stress ECG system market is estimated at $200M, and the total standard ECG installed base represents an estimated $800M market for the new product."

CE mark was also granted to BSP's software product - the HyperQ-AN. This product enables analysis with the unique HyperQ technology and can be employed in OEM and licensing business models in existing commercial stress ECG systems, such as the company's collaboration with Schiller AG.

About BSP

Founded in 2000, BSP is dedicated to providing novel, risk free and highly reliable solutions for the diagnosis and monitoring of cardiovascular disease. BSP's proprietary HyperQ(TM) technology is implemented in cardiac systems that offer accurate, low-cost and risk free cardiac monitoring and allows, for the first time, an effective diagnosis of ischemic heart disease in broad populations. BSP is a traded company on the Tel Aviv Stock Exchange since 2006 (TASE:BSP). The company's international offices are located in Tel Aviv, Israel and Rockville, Maryland, USA.

    For more information please contact:

    Nissim Greisas, CEO, Biological Signal Processing Ltd.
    nissim@bspmedical.com
    Tel. +972-3-6474840



'/>"/>
SOURCE BSP - Biological Signal Processing Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tolera Therapeutics Granted Orphan Drug Designation for Treatment of Type 1 diabetes mellitus
2. MultiCell Technologies Is Granted European Patent for the Treatment of Cancer
3. Solos Endoscopy, Inc. Granted U.S. Trademark for MammoView(R)
4. Acuo Technologies Announces Patent Granted for Asset Communication Format Within a Computer Network
5. Curemark CM-AT Autism Treatment Granted FDA Fast Track Status
6. SPO Medical Granted Innovative Baby Monitoring Patent
7. First iPierian Patent for Induced Pluripotent Stem Cell Technology Granted by United Kingdom Intellectual Property Office
8. FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
9. Emergency Use Authorization Granted For BioCrysts Peramivir
10. MultiCell Technologies is Granted U.S. Patent for Immortalized Human Liver Cell Lines
11. Essentialis Meets Primary Endpoint in Phase 2b Trial of DCCR for Treatment of Hypertriglyceridemia and is Granted Extensive Patent Coverage in the US
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... , Dec. 6, 2016 In this age ... to be hopeful.  A special kind of sunglasses, from ... anxious life. Photo - http://photos.prnewswire.com/prnh/20161205/445444 ... Robert Buck, the psychotherapist who developed and patented the ... to overcoming anxiety and worry.  "Anxiety doesn,t have ...
(Date:12/5/2016)... , Dec. 5 2016 United ... Summary GlobalData,s new report, "United Kingdom ... key market data on the United Kingdom Ophthalmic ... millions of US dollars, volume (in units) and ... Coherence Tomography (OCT), Retinal Ultrasound Imaging Systems, Corneal ...
(Date:12/5/2016)...   Mallinckrodt Pharmaceuticals (NYSE: MNK ... that it received a perfect score of 100 percent ... benchmarking survey and report on corporate policies and practices ... equality, administered by the Human Rights Campaign (HRC) Foundation. ... which also earned top marks this year. ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... ... released the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has ... the world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every ...
(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , Mobility Scooters give freedom to people who need help getting around. For some, ... facing a long period of rehabilitation after an illness or accident. There is a ...
(Date:12/5/2016)... ... 05, 2016 , ... "FCPX Overlay Glare is a tool that utilizes light ... rendering or complicated compositing," said Christina Austin - CEO of Pixel Film Studios. ... of lights that simulates the look of a glare. Just drag and drop ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... security executive networking and relationship-marketing firm, announced today that nominations will be ... Information Security Executive® (ISE®) Central Awards. , Awards include the Information Security ...
(Date:12/5/2016)... Isles Beach, Fla (PRWEB) , ... December 05, ... ... E. Herman as Keynote speaker for the 21st Annual International Congress on Hematologic ... making the announcement, PER® president, Phil Talamo said, “We are honored to have ...
Breaking Medicine News(10 mins):